Registration, Annual and Special Reporting
Home > Firm Summary
|
For a list of issuers (if any) that the firm has audited, or in whose audits the firm has played a substantial role, see Part IV of the firm's annual reports.
|
Annual and Special Reporting by the Firm
Auditor Reporting of Certain Audit Participants
Form | Filed Date | Issuer Name | Audit Report Date | Engagement Partner | |
Form AP
|
02/26/2024
|
Genmab A/S
|
02/14/2024
|
Jensen, Torben
|
|
Form AP
|
03/06/2023
|
Genmab A/S
|
02/22/2023
|
Jensen, Torben
|
|
Form AP
|
05/20/2022
|
Allarity Therapeutics Inc.
|
08/20/2021
|
Jensen, Torben
|
|
Form AP
|
03/10/2022
|
Genmab A/S
|
02/16/2022
|
Jørgensen, Rasmus Friis
|
|
Form AP
|
08/27/2021
|
Allarity Therapeutics A/S
|
08/20/2021
|
Jensen, Torben
|
|
Form AP
|
04/13/2021
|
Genmab A/S
|
03/29/2021
|
Jørgensen, Rasmus Friis
|
|
Form AP
|
03/03/2021
|
Novo Nordisk
|
02/03/2021
|
Melgaard, Mads
|
|
Form AP
|
04/20/2020
|
Genmab A/S
|
03/30/2020
|
Jørgensen, Rasmus Friis
|
|
Form AP
|
03/01/2020
|
Novo Nordisk
|
02/05/2020
|
Melgaard, Mads
|
|
Form AP
|
06/03/2019
|
Genmab A/S
|
04/01/2019
|
Jørgensen, Rasmus Friis
|
|
Form AP
|
02/26/2019
|
Novo Nordisk
|
02/01/2019
|
Melgaard, Mads
|
|
Form AP
|
02/27/2018
|
Novo Nordisk
|
02/01/2018
|
Jensen, Torben
|
|
Form AP
|
02/10/2017
|
Novo Nordisk
|
02/01/2017
|
Jensen, Torben
|
|
|
Currently Subject to Board Determination Under the Holding Foreign Companies Accountable Act?
|